CAMP FY 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+436.5% YoY

Gross Profit

$2M53.1% margin

Operating Income

-$52M-1488.3% margin

Net Income

-$80M-2298.5% margin

EPS (Diluted)

$-2.65

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$118M

Total Liabilities

$70M

Stockholders' Equity

$48M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$652,000	+436.5%
Gross Profit	$2M	$652,000	+185.1%
Operating Income	-$52M	-$53M	+1.9%
Net Income	-$80M	-$52M	-55.2%